The multi-stakeholder world is increasingly complex, with shifting dynamics and stakeholder groups engaging in different ways, through different channels, at different times and by different customer-facing functions. Navigating this complex interplay continues to be one of the biggest challenges facing the industry.
Find out more by downloading your free copy today >>>
In this whitepaper, we examine:
The influence of three key groups of stakeholders – Patients (and their support ecosystems); HCPs and Providers; and Payers/ Policy Makers in shaping key decision-making within healthcare systems today
What leaders at Actelion, Pfizer and Bayer believe a multi-stakeholder approach looks like
The benefits of aligning your commercial structure around multiple stakeholders including consistent and cohesive messaging.
Download your copy of the content now >>>
With expert contributions from:
Hans Gilhuyus, Global Multi Channel Capabilities Director, GSK
Jane Griffiths, Global Head, Actelion
Markus Kosch, Vice President, Oncology Portfolio, Europe, Japan & Developed Asia, Pfizer Oncology
Sebastian Guth, Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals
Barrett Madrigal, Senior Director Eli Lilly Japan KK. Operation Officer, Member of Global Bio-Medicines Lead Team
Bob Oliver, Chief Executive Officer, VClinBio
Kabir Nath, CEO, Otsuka Pharmaceuticals US
Discover how the integrated multi-channel approach will change pharma, download your copy today >>>
Please let me know if you have any feedback.
Whitepaper: Balancing payers, patients and physicians